TrialInternational journal of urology : official journal of the Japanese Urological Association2022

Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors.

Takashi Kawahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.